Market Capitalization of Parmax Pharma (PARMAX)
As of July 24, 2026, Parmax Pharma (PARMAX) market capitalisation is ₹39.27 Cr ($4.36M), with 38.19 L shares outstanding at a current price of ₹102.83 on BSE, ranking 3916 out of 5363 companies by market cap in our screener. Parmax Pharma operates in the Healthcare sector and is classified as a Small Cap stock. Compare with Parmax Pharma value estimation to assess whether the stock is under or overvalued.
Market Cap History of Parmax Pharma (Last 10 Years)
PARMAX market capitalisation from year-end BSE closing prices over the last 10 years. View PARMAX annual price range for the annual high/low range and current price position.
End of Year Market Cap History — Parmax Pharma
PARMAX year-end market cap in INR and USD with closing share price and annual change — BSE closing prices. For live price, earnings and the complete company profile, see Parmax Pharma share price chart.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹39.27 Cr
$4.36M USD
|
₹102.83 | BSE | +203.96% |
| 2025 |
₹12.92 Cr
$1.44M USD
|
₹33.83 | BSE | -23.55% |
| 2024 |
₹16.90 Cr
$1.88M USD
|
₹44.25 | BSE | +35.86% |
| 2023 |
₹12.44 Cr
$1.38M USD
|
₹32.57 | BSE | -15.84% |
| 2022 |
₹14.78 Cr
$1.64M USD
|
₹38.70 | BSE | -35.45% |
| 2021 |
₹22.89 Cr
$2.54M USD
|
₹59.95 | BSE | +103.22% |
| 2020 |
₹11.27 Cr
$1.25M USD
|
₹29.50 | BSE | +63.89% |
| 2019 |
₹6.87 Cr
$763,785 USD
|
₹18.00 | BSE | +4.05% |
| 2018 |
₹6.61 Cr
$734,082 USD
|
₹17.30 | BSE | +1.76% |
| 2017 |
₹6.49 Cr
$721,352 USD
|
₹17.00 | BSE | - |